StartseitePodcastsThe Long Run with Luke TimmermanEp209: Mathai Mammen on Developing Drugs Against Undruggable TargetsThe Long Run with Luke TimmermanEp209: Mathai Mammen on Developing Drugs Against Undruggable Targets09.09.2026 · 1 Std. 36 Min.Folge abspielenAb dieser Stelle teilenShownotesMathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.Alle Folgen von The Long Run with Luke Timmerman